Date: 08–10 July 2026
Venue: Queen Sirikit National Convention Center (QSNCC), Bangkok, Thailand
Booth No: J.28
Fanttest cordially invites global distributors, healthcare professionals, and industry partners to visit Booth J.28. Our experienced sales and technical teams will provide on-site product demonstrations, professional technical consultation and tailored cooperation solutions, staiming to unlock sustainable, mutually beneficial business opportunities across the ASEAN market.
Backed by our own standardized manufacturing facilities, comprehensive international regulatory certifications, Fanttest delivers complete integrated IVD solutions. Paired with self-developed colloidal gold readers and matched reagent kits, our locally adapted system seffectively address key healthcare challenges in Southeast Asia, including insufficient standardized testing equipment, limited screening items and unstable regional supply chains.
We bring a well-tiered product portfolio for this exhibition, covering mature mainstream demands, year-round essential screening and newly upgraded high-value niche solutions, fully adapting to Southeast Asia’s public health and civilian health management needs.
Proven through long-term market validation, our tropical epidemic detection products maintain stable and reliable performance. Widely applied in public screening, border inspection and grassroots clinical scenarios, this mature lineup features high market recognition and continuous repurchase demand, serving as a steady revenue pillar for regional partners.
Covering both professional institutional diagnosis and household self-testing scenarios, our dual-version screening panels are designed for year-round use across diverse healthcare settings. Compatible with our self-developed reading devices, the series standardizes clinical detection and facilitates daily health monitoring, supporting partners’ long-term and stable market operation.
Our newly launched specialized screening lineup covers Syp, Chlamydia & Gonorrhea combo tests, urinary tract infection (UTI) and drug of abuse (DOA) tests. targeting underserved niche markets in primary healthcare and public health systems, with low market competition and high added value, it creates new profit growth points and differentiated competitive advantages for forward-looking global partners.
Fanttest provides solid comprehensive cooperation strengths Supported by stable mass production capacity,full regulatory compliance in target markets and multi-lingual regional customization services, we ensuring stable global supply and smooth market entry.
As a core ASEAN healthcare hub, Thailand has strong growth potential in the IVD market.Driven by technological innovation and localized medical empowerment,By enhancing tropical disease diagnostic solutions and stabilizing regional supply chains, Fanttest is dedicated to forging long-term strategic partnerships to drive sustainable growth in Southeast Asia’s healthcare and IVD sector.
